Gene · 7498
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435231 | PubTator, text mining | PubMed |
| Clinical and Functional Assessment of Digenicity in Renal Phosphate Wasting. | Nutrients | 2023 | 37432176 | PubTator, text mining | PubMed |
| [Effects of auricular thumbtack needle on lactation function and TDP-43/Btn1A1/XDH pathway in primiparous women with cesarean section]. | Zhongguo Zhen Jiu | 2023 | 37429656 | PubTator, text mining | PubMed |
| Characterizations of microRNAs involved in the molecular mechanisms underlying the therapeutic effects of noni (Morinda citrifolia L.) fruit juice on hyperuricemia in mice. | Front Nutr | 2023 | 37426193 | PubTator, text mining | PubMed |
| A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. | BMC Med Genomics | 2023 | 37422662 | PubTator, text mining | PubMed |
| Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure. | Respir Res | 2023 | 37415141 | PubTator, text mining | PubMed |
| A histological analysis of coloration in the Peruvian mimic poison frog (Ranitomeya imitator). | PeerJ | 2023 | 37404476 | PubTator, text mining | PubMed |
| Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components. | Front Nutr | 2023 | 37377486 | PubTator, text mining | PubMed |
| Adenylosuccinic Acid: An Orphan Drug with Untapped Potential. | Pharmaceuticals (Basel) | 2023 | 37375769 | PubTator, text mining | PubMed |
Effects of Dietary Nitrate Supplementation on Performance during Single and Repeated Bouts of Short-Duration High-Intensity Exercise: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. | Antioxidants (Basel) | 2023 | 37371924 | PubTator, text mining | PubMed |
| The Effect of Diosmin, Escin, and Bromelain on Human Endothelial Cells Derived from the Umbilical Vein and the Varicose Vein-A Preliminary Study. | Biomedicines | 2023 | 37371797 | PubTator, text mining | PubMed |
| A New Pattern of Brain and Cord Gadolinium Enhancement in Molybdenum Cofactor Deficiency: A Case Report. | Children (Basel) | 2023 | 37371303 | PubTator, text mining | PubMed |
| Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis. | Redox Biol | 2023 | 37364513 | PubTator, text mining | PubMed |
| Prospects of evolution-based artificial intelligence models in genome-wide studies to stratify genetic risk variants in nonalcoholic fatty liver disease. | Ann Med Surg (Lond) | 2023 | 37363524 | PubTator, text mining | PubMed |
| Flexible multi-client functional encryption for set intersection. | J Supercomput | 2023 | 37359335 | PubTator, text mining | PubMed |
| Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37357527 | PubTator, text mining | PubMed |
Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling. | Theranostics | 2023 | 37351165 | PubTator, text mining | PubMed |
| NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. | Front Oncol | 2023 | 37342194 | PubTator, text mining | PubMed |
| The correlation between dietary inflammatory index and risk of hyperuricemia in the U.S. population. | Medicine (Baltimore) | 2023 | 37335705 | PubTator, text mining | PubMed |
| Uric acid and neurological disease: a narrative review. | Front Neurol | 2023 | 37333005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7498/papers?page=24